CV Sciences, Inc. to Participate at the 22nd Annual ICR Conference
08 janv. 2020 08h45 HE
|
CV Sciences, Inc.
SAN DIEGO, Jan. 08, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
Tim Hitchman, PhD, Joins CV Sciences, Inc. as Director of Operations
17 déc. 2019 08h45 HE
|
CV Sciences, Inc.
Hitchman Brings Deep Experience in Product Development, Commercialization and Operations SAN DIEGO, Dec. 17, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”,...
CV Sciences to Present at the 12th Annual LD Micro Main Event
03 déc. 2019 08h45 HE
|
CV Sciences, Inc.
SAN DIEGO, Dec. 03, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Announces New Distribution Partnership With Southeastern Grocers
11 nov. 2019 08h45 HE
|
CV Sciences, Inc.
New Partnership with Southeastern Grocers Launches PlusCBD™ Oil Topical Products and Dietary Supplements at 115 Winn-Dixie Stores in Florida and 37 BI-LO Stores in South Carolina SAN DIEGO, Nov. 11,...
CV Sciences, Inc. Reports Third Quarter 2019 Financial Results
05 nov. 2019 16h00 HE
|
CV Sciences, Inc.
Increased Retail Distribution by Over 800 Stores SAN DIEGO, Nov. 05, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent...
CV Sciences, Inc. Applauds USDA’s Establishment of the U.S. Domestic Hemp Production Program
30 oct. 2019 08h45 HE
|
CV Sciences, Inc.
Program Creates a Consistent Regulatory Framework for Hemp Production Throughout the United States SAN DIEGO, Oct. 30, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV...
CV Sciences, Inc. Appoints Beth Altman to its Board of Directors
29 oct. 2019 08h45 HE
|
CV Sciences, Inc.
SAN DIEGO, Oct. 29, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. to Sponsor 26th Annual HIACON Conference in Charlotte, North Carolina on Nov. 1-4, 2019
24 oct. 2019 08h45 HE
|
CV Sciences, Inc.
SAN DIEGO, Oct. 24, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. to Announce Third Quarter 2019 Results on November 5, 2019
23 oct. 2019 08h00 HE
|
CV Sciences, Inc.
SAN DIEGO, Oct. 23, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Appoints Dr. Paul Blake to its Board of Directors
22 oct. 2019 08h45 HE
|
CV Sciences, Inc.
SAN DIEGO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...